CINDILEE LUKACS: Open Payments
NPI 1245502210 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 14 payments from 8 companies in 2025. Trend: 2023 $448 · 2024 $368 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $91 |
| Phathom Pharmaceuticals, Inc. | 5 | $61 |
| ABBVIE INC. | 2 | $45 |
| Madrigal Pharmaceuticals | 1 | $37 |
| Aimmune Therapeutics, Inc. | 2 | $31 |
| Exact Sciences Corporation | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $13 |
Products named: ENTYVIO, VOQUEZNA, REZDIFFRA, ZENPEP, MAVYRET, The Cologuard Plus Collection Kit, CREON, XIFAXAN.
Industry payments across FL — which companies pay providers there.
